Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 14.15
- Piotroski Score 3.00
- Grade Buy
- Symbol (KURA)
- Company Kura Oncology, Inc.
- Price $17.52
- Changes Percentage (-1.66%)
- Change -$0.3
- Day Low $17.24
- Day High $18.06
- Year High $24.17
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/06/2024
- Fiscal Year End N/A
- Average Stock Price Target $26.50
- High Stock Price Target $32.00
- Low Stock Price Target $19.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.17
- Trailing P/E Ratio -10.03
- Forward P/E Ratio -10.03
- P/E Growth -10.03
- Net Income $-152,631,000
Income Statement
Quarterly
Annual
Latest News of KURA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Exploring SAKURA Internet And Two Other High Growth Tech Stocks In Japan
In the midst of Japan's stock market decline, investors are eyeing high-growth sectors like technology for opportunities. Companies like SAKURA Internet Inc. and Nissha Co., Ltd. are showing promise w...
By Yahoo! Finance | 1 week ago -
Can Philipp Kurashev produce without Connor Bedard? The Blackhawks' fate could hinge on it
Philipp Kurashev unexpectedly thrived playing alongside Connor Bedard last season, showcasing newfound offensive prowess. Now tasked with leading his own line, Kurashev aims to prove his value as a pr...
By The New York Times | 3 weeks ago -
Kura Sushi USA Clears Technical Benchmark, Hitting 80-Plus RS Rating
Learn how to trade options effectively by choosing the right strategy for the best results. Investor's Business Daily's exclusive rating system helps identify market leaders based on a score of 1 to 9...
By Investor's Business Daily | 3 weeks ago
